Cuál es el precio por Fresh Tracks Therapeutics, Inc. (FRTX)

Precio por Fresh Tracks Therapeutics, Inc. (FRTX) es de$0.94

Cuál es la capitalización de mercado por Fresh Tracks Therapeutics, Inc. (FRTX)

Capitalización de mercado por Fresh Tracks Therapeutics, Inc. (FRTX) es $2.73M

Fresh Tracks Therapeutics, Inc. (FRTX) Desdoblamientos de Acciones

Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
2022-07-05	1:45	x0.022222222222222	x0.00031746031746032
2019-09-03	1:7	x0.14285714285714	x0.014285714285714
2016-05-27	1:10	x0.1	x0.1

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

2022-07-05

1:45

x0.022222222222222

x0.00031746031746032

2019-09-03

1:7

x0.14285714285714

x0.014285714285714

2016-05-27

1:10

x0.1

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País